Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate for general anesthesia induction in obese patients
ChiCTR2100053141Phase 4Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in obesity (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: The ratio of successful induction of anesthesia. Started Nov 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2100053141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053141.